Send to

Choose Destination
Biomed Chromatogr. 2012 Dec;26(12):1502-8. doi: 10.1002/bmc.2724. Epub 2012 Mar 8.

Metabolism studies of casticin in rats using HPLC-ESI-MS(n).

Author information

Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.


Casticin (3',5-dihydroxy-3, 4',6,7-tetramethoxyflavone) has been revealed to possess various kinds of pharmacological activities, including immunomodulatory, anti-hyperprolactinemia, anti-tumor and neuroprotetective activities. In order to gain an understanding of the biotransformation of casticin in vivo, a systematic method based on liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS(n) ) was developed to identify the metabolites of casticin in rats after oral administration of single dose of casticin at 200 mg/kg. By comparing their changes in molecular masses (ΔM), retention times and spectral patterns with those of the parent drug, the parent compound and 25 metabolites were identified in rat plasma, urine and six selected tissues. This is the first systematic metabolism study of casticin in vivo. The results indicated that methylation, demethylation, glucuronidation and sulfation were the main biotransformation pathways of casticin in vivo.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center